You may have heard that from the 23rd June 2025, GPs can prescribe Tirzepatide (Mounjaro) for weight loss.
However, the Birmingham and Solihull Integrated Care Board (BSOL ICB) is still finalizing how this will be provided.
It is expected to be offered through local clinics, as there has been no planning from the ICB to provide it via individual GP practice.
Initially, the treatment will be available only to people with a BMI over 40 who also have four weight-related health conditions such as:
- High Blood Pressure
- High Cholesterol (hypercholesterolemia)
- Sleep Aponea
- Heart Disease
- Type 2 Diabetes
This service is not yet operational.
Please do not book appointments specifically to request this medication at this time, as it cannot be provided yet.
What you need to know
- We will notify you as soon as the service is available.
- When it starts, eligible patients will be invited to participate.
- Doctors will review patient records to identify those who qualify.
For the latest updates, please visit the ICB website:
The ICB’s website is regularly updated as the situation develops.